Alessandra Leone

Has grant

Fondazione IRCCS Istituto Nazionale dei Tumori

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Cancer Biology Cancer Biology professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Pharmacological targeting of CtBP1/BARS in cancer

Open Date: 2020-11-01

Close Date: 2023-11-01

Articles (8)

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (2)

Alfredo Budillon

Chief Experimental Pharmacology Unit

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Salvatore Valiante

Associate professor

University of Naples Federico II

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Alessandra Leone

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (8)

HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation

Inhibition of autophagy by chloroquine prevents resistance to PI3K/AKT inhibitors and potentiates their antitumor effect in combination with paclitaxel in triple negative breast cancer models

Effect of Bevacizumab in Combination With Standard Oxaliplatin-Based Regimens in Patients With Metastatic Colorectal Cancer

Valproic Acid Synergizes With Cisplatin and Cetuximab in vitro and in vivo in Head and Neck Cancer by Targeting the Mechanisms of Resistance

Synergistic antitumor interaction of valproic acid and simvastatin sensitizes prostate cancer to docetaxel by targeting CSCs compartment via YAP inhibition

Targeting Autophagy in Breast Cancer

Large extracellular vesicles: Size matters in tumor progression

Randomized phase II study of valproic acid in combination with bevacizumab and oxaliplatin/fluoropyrimidine regimens in patients with<i>RAS</i>-mutated metastatic colorectal cancer: the REVOLUTION study protocol

Collaborators (2)

Alfredo Budillon

Salvatore Valiante

Make your next move.